The effect of prolonged therapy with MMX™ mesalamine in patients with acute, mild-to-moderate ulcerative colitis

被引：0
|
作者：
Lichtenstein, Gary R.
Kamm, Michael A.
Panaccione, Remo
Barrett, Karen
Lees, Kirstin
Joseph, Raymond E.
机构：
[1] Univ Penn, Div Gastroenterol, Philadelphia, PA 19104 USA
[2] St Marks Hosp, Dept Gastroenterol, London EC1V 2PS, England
[3] Univ Calgary, Div Gastroenterol, Calgary, AB T2N 1N4, Canada
[4] Shire Pharmaceut Inc, Basingstoke, Hants, England
[5] Shire Pharmaceut Inc, Wayne, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2007年 / 102卷
关键词：
D O I：
10.14309/00000434-200709002-00940
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
940
引用
收藏
页码：S463 / S463
页数：1
相关论文
共 50 条
  • [1] Effect of Extended MMX Mesalamine Therapy for Acute, Mild-to-Moderate Ulcerative Colitis
    Kamm, Michael A.
    Lichtenstein, Gary R.
    Sandborn, William J.
    Schreiber, Stefan
    Lees, Kirstin
    Barrett, Karen
    Joseph, Raymond
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (01) : 1 - 8
  • [2] MMX™ mesalamine for the maintenance of remission in mild-to-moderate ulcerative colitis
    Sandborn, W.
    Kamm, M.
    Lichtenstein, G.
    Barrett, K.
    Joseph, R.
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (01) : S24 - S24
  • [3] Satisfaction with therapy among patients treated with MMX™ mesalamine for maintenance of remission in patients with mild-to-moderate ulcerative colitis
    Sandborn, W.
    Lichtenstein, G.
    Kamm, M.
    Barrett, K.
    Joseph, R.
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (01) : S24 - S24
  • [4] Time to initial symptom resolution with MMX™ mesalamine therapy for active, mild-to-moderate ulcerative colitis
    Sandborn, William J.
    Karlstadt, Robyn
    Barrett, Karen
    Joseph, Raymond E.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S462 - S463
  • [5] Multi-Matrix System (MMX®) mesalamine for the treatment of mild-to-moderate ulcerative colitis
    Horst, Sara N.
    Kane, Sunanda
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (15) : 2225 - 2232
  • [6] MMX® mesalamine treatment for patients with mild-to-moderate ulcerative colitis: improvement in health-related quality of life
    Kane, S.
    Yen, L.
    Yarlas, A.
    Karlstadt, R.
    Solomon, D.
    Hodgkins, P.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A92 - A92
  • [7] MMX™ mesalamine is effective for the maintenance of remission of mild-to-moderate ulcerative colitis irrespective of patients' previous relapse history
    Sandborn, William J.
    Karlstadt, Robyn
    Barrett, Karen
    Joseph, Raymond E.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S461 - S462
  • [8] MMX mesalamine for the treatment of active mild-to-moderate ulcerative colitis: An evidence-based medicine analysis
    Sandborn, William J.
    Lichtenstein, Gary R.
    Kamm, Michael A.
    Barrett, Karen
    Joseph, Raymond E.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S431 - S432
  • [9] MMX mesalamine for providing remission of active mild-to-moderate ulcerative colitis: An evidence-based medicine analysis
    Hanauer, S.
    Sandborn, W.
    Lichtenstein, G.
    Kamm, M.
    Barrett, K.
    Joseph, R.
    [J]. INFLAMMATORY BOWEL DISEASES, 2007, 13 (05) : 663 - 663
  • [10] Induction of mucosal healing in mild-to-moderate ulcerative colitis in patients treated with MMX⊙ mesalamine: established versus newly diagnosed disease
    Lichtenstein, G.
    Sandborn, W.
    Kamm, M.
    Solomon, D.
    Karlstadt, R.
    Barrett, K.
    Abhyankar, B.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S35 - S35
12345